C7H5Cl2NO4S 270.09

Benzoic acid, 4-[(dichloroamino)sulfonyl]-.
p-(Dichlorosulfamoyl)benzoic acid [80-13-7].

Packaging and storage— Preserve in tight, light-resistant containers.

Identification— Add about 100 mg to 5 mL of sodium bromide solution (1 in 10): bromine is liberated from the mixture.

Loss on drying 731— Dry it over phosphorus pentoxide for 4 hours: it loses not more than 0.5% of its weight.

Readily carbonizable substances 271— Dissolve 100 mg in 0.5 mL of sulfuric acid TS: no blackening occurs, although some effervescence may take place.

Residual solvents 467: meets the requirements.

Assay— Add about 150 mg of Halazone, accurately weighed, to 10 mL of 2.5 N sodium hydroxide in a 250-mL iodine flask, stir well to dissolve, add 75 mL of water, then promptly add 15 mL of potassium iodide solution (1 in 10), and mix. Acidify with 10 mL of 6 N acetic acid, and immediately titrate the liberated iodine with 0.1 N sodium thiosulfate VS, adding 3 mL of starch TS as the endpoint is approached. Perform a blank determination, and make any necessary correction. Each mL of 0.1 N sodium thiosulfate is equivalent to 6.752 mg of C7H5Cl2NO4S.

Expert Committee : (GTMDB05) General Toxicology and Medical Device Biocompatibility

USP29–NF24 Page 1040

Phone Number : 1-301-816-8339